Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
News
Join Us
Contact
DONATE
< Back to News
Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals’ VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme
JUNE 4, 2020 | PRNEWSWIRE
https://www.prnewswire.com/news-releases/global-coalition-for-adaptive-research-gcar-selects-delmar-pharmaceuticals-val-083-to-participate-in-the-gbm-agile-pivotal-study-an-adaptive-clinical-trial-platform-in-glioblastoma-multiforme-301070586.html
Home
Leadership
About REMAP-COVID
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE